glp-1 receptor agonists in pediatric and adolescent obesity GLP1 Agonists—Effects beyond Diabetes GLP‐1 Agonists for Pediatric Psychopharmacology:
Description
Fall risk assessment should be included in the monitoring protocol, as rapid weight loss can affect balance and bone density
Funding There is no funding associated with this project
The most common side effects include: Nausea Loss of appetite Diarrhea Vomiting Dizziness Headaches Indigestion Rapid heart rate Infection Itchiness or redness at injection sites Side effects are usually mild to moderate
Social determinants such as education, income, and community environment, along with adverse childhood experiences, can disrupt the metabolic and epigenetic processes that regulate body weight [2]
If you experience syncope or near-syncope, avoid driving or operating machinery until evaluated by your healthcare provider
The supplement stack for transition Certain supplements can support the transition off GLP-1 medications
